Literature DB >> 18291626

Selective attention deficits reflect increased genetic vulnerability to schizophrenia.

Francesca M Filbey1, Timothea Toulopoulou, Robin G Morris, Colm McDonald, Elvira Bramon, Muriel Walshe, Robin M Murray.   

Abstract

BACKGROUND: Impairment in attention is prominent in schizophrenia and may be a valuable genetic indicator for vulnerability to this disease. AIMS: We set out to characterize the attention deficits that may be associated with genetic liability to schizophrenia.
METHODS: We compared attention performance in 55 people with schizophrenia, 95 of their first-degree relatives, and 61 unrelated controls. We also segregated presumed obligate carriers of genetic risk (POCs, N=12) and compared their performance with that of controls.
RESULTS: Although the relatives of people with schizophrenia did not significantly differ from the normal controls on the tasks of attention, their scores were significantly ordered such that patients>relatives>normal controls during tasks of sustained and selective attention as measured by the Jonckheere-Terpstra Test (p<.05). Additionally, POCs were significantly worse than normal controls during selective attention tasks such as the Stroop (p=.03) and Letter Cancellation Task (p=.04).
CONCLUSIONS: Heterogeneity in the first-degree relatives may have diluted the attention deficits present in those who are at genetic risk for schizophrenia. On the other hand, our findings in the more homogeneous group of POCs suggest that selective attention may be an indicator of genetic liability for schizophrenia.

Entities:  

Mesh:

Year:  2008        PMID: 18291626     DOI: 10.1016/j.schres.2008.01.019

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  8 in total

1.  Altered integrity of the right arcuate fasciculus as a trait marker of schizophrenia: a sibling study using tractography-based analysis of the whole brain.

Authors:  Chen-Hao Wu; Tzung-Jeng Hwang; Yu-Jen Chen; Yun-Chin Hsu; Yu-Chun Lo; Chih-Min Liu; Hai-Gwo Hwu; Chen-Chung Liu; Ming H Hsieh; Yi Ling Chien; Chung-Ming Chen; Wen-Yih Isaac Tseng
Journal:  Hum Brain Mapp       Date:  2014-11-04       Impact factor: 5.038

2.  Activation of the caudal anterior cingulate cortex due to task-related interference in an auditory Stroop paradigm.

Authors:  Sven Haupt; Nikolai Axmacher; Michael X Cohen; Christian E Elger; Juergen Fell
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

Review 3.  Cognitive control deficits in schizophrenia: mechanisms and meaning.

Authors:  Tyler A Lesh; Tara A Niendam; Michael J Minzenberg; Cameron S Carter
Journal:  Neuropsychopharmacology       Date:  2010-09-15       Impact factor: 7.853

Review 4.  Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions.

Authors:  Jim van Os; Bart Pf Rutten; Richie Poulton
Journal:  Schizophr Bull       Date:  2008-09-12       Impact factor: 9.306

Review 5.  A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia.

Authors:  Martin Sarter; Vicente Martinez; Rouba Kozak
Journal:  Psychopharmacology (Berl)       Date:  2008-07-10       Impact factor: 4.530

6.  Continuous performance test impairment in a 22q11.2 microdeletion mouse model: improvement by amphetamine.

Authors:  Simon R O Nilsson; Christopher J Heath; Samir Takillah; Steve Didienne; Kim Fejgin; Vibeke Nielsen; Jacob Nielsen; Lisa M Saksida; Jean Mariani; Philippe Faure; Michael Didriksen; Trevor W Robbins; Timothy J Bussey; Adam C Mar
Journal:  Transl Psychiatry       Date:  2018-11-14       Impact factor: 6.222

7.  Resting state and task-induced deactivation: A methodological comparison in patients with schizophrenia and healthy controls.

Authors:  Maggie V Mannell; Alexandre R Franco; Vince D Calhoun; Jose M Cañive; Robert J Thoma; Andrew R Mayer
Journal:  Hum Brain Mapp       Date:  2010-03       Impact factor: 5.038

8.  An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use.

Authors:  Else-Marie Løberg; Merethe Nygård; Jan Øystein Berle; Erik Johnsen; Rune A Kroken; Hugo A Jørgensen; Kenneth Hugdahl
Journal:  Front Psychiatry       Date:  2012-10-30       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.